The document discusses a study that measured concentrations of prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid (CSF) of patients with Huntington's disease (HD) compared to control patients. The study found increased levels of all three proteins in the CSF of HD patients. This suggests the proteins are produced directly in the central nervous system and their levels in CSF are not related to their serum concentrations. Elevated biomarkers in CSF could help track HD progression and indicate central nervous system involvement in the disease.